HACKENSACK MERIDIAN HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 2016-01-01

Employees: -

Market Cap: -

Website: https://www.hackensackmeridianhealth.org/

Clinical Trials

Hold Parameters on Likely Cardiovascular Depressant Medications

Withdrawn

Conditions: Hypotension
Asystole
Bradycardia

First Posted Date: 2007-09-11

Last Posted Date: 2020-08-05

Lead Sponsor: Hackensack Meridian Health

Registration Number: NCT00527709

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture

Terminated

Conditions: Breast Cancer

First Posted Date: 2007-06-01

Last Posted Date: 2014-02-04

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 13

Registration Number: NCT00481585

Locations: 🇺🇸
Hackensack Univeristy Medical Center, Hackensack, New Jersey, United States

A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma

Phase 2

Terminated

Conditions: Multiple Myeloma

Interventions: Drug: Bortezomib

First Posted Date: 2007-04-23

Last Posted Date: 2022-07-20

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 7

Registration Number: NCT00464178

Locations: 🇺🇸
The Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

Lived Experiences of Adolescents in the Treatment Process of Cancer and the Impact on Occupations

Completed

Conditions: Pediatric Cancer

First Posted Date: 2007-04-04

Last Posted Date: 2014-02-04

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 4

Registration Number: NCT00456209

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

Phase 3

Withdrawn

Conditions: Melanoma (Skin)

First Posted Date: 2007-03-14

Last Posted Date: 2013-05-13

Lead Sponsor: Hackensack Meridian Health

Registration Number: NCT00447356

Locations: 🇺🇸
The Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

Remote Presence Timely Discharge Management

Phase 2

Withdrawn

Conditions: Patient Discharge

First Posted Date: 2006-08-15

Last Posted Date: 2013-05-07

Lead Sponsor: Hackensack Meridian Health

Registration Number: NCT00364117

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.

Completed

Conditions: Sleep Disorders
COPD

First Posted Date: 2006-06-30

Last Posted Date: 2014-02-04

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 50

Registration Number: NCT00346554

Locations: 🇺🇸
Hackensack University Medical Center - Pulmonary Rehabilitation, Hackensack, New Jersey, United States

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

First Posted Date: 2004-08-23

Last Posted Date: 2013-05-30

Lead Sponsor: Hackensack Meridian Health

Registration Number: NCT00004906

Locations: 🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Ireland Cancer Center, Cleveland, Ohio, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

and more 1 locations

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

First Posted Date: 2004-08-20

Last Posted Date: 2013-05-30

Lead Sponsor: Hackensack Meridian Health

Registration Number: NCT00004900

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy